Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and... see more

TSX:CRON - Post Discussion

Cronos Group Inc > ENTG Extends Primary Credit Facility with BMO/Others 2+Years
View:
Post by Wrywisdom on Jul 15, 2022 1:18pm

ENTG Extends Primary Credit Facility with BMO/Others 2+Years

For those not aware, Entourage has extended and improved it's primary credit facility with Bank of Montreal for two more years, furthering it's relationship with one of Canada's most prestigious and established financial institutions. 

It also has extended it's agreements with secondary lenders beyond two years, with the flexibility to pay only interest at the discretion of Entourage.

Add to that revenues soaring every quarter (now more than 60 million dollars over the past 4 quarters), and they are firmly positioned to implement the entirety of their extraordinariy multifaceted strategy in the recreational and medical markets;  as well as furthering their synergies with Boston Beer, Mary's Medicinals, Fire and Flower, and much more. 

https://stockhouse.com/news/press-releases/2022/07/04/entourage-health-announces-amendments-to-its-credit-facilities-to-improve-debt

ENTG Revenues  should exceed expenses by the autumn as the growth and expansion phase winds down, and the revenues from expanded production tiers soar.

Simply a stellar opportunity here.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities